NATURAL KILLER CELLS IN TUMOUR-BEARING PATIENTS11Support for this work was received from the Ontario Cancer Treatment and Research Foundation (HFP) and the Medical Research Council of Canada (MGB).
- 1 January 1980
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- K562—A human erythroleukemic cell lineInternational Journal of Cancer, 1979
- Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cellsAmerican Journal of Obstetrics and Gynecology, 1978
- Lymphocyte Mediated Natural Cytotoxicity in NeoplasiaOncology, 1978
- Immunocompetent cells in patients with malignant disease.I. the lack of naturally occurring killer cell activity in the unfractionated circulating lymphocytes from patients with chronic lymphocytic leukemia (CLL)Cancer, 1976
- Spontaneous human lymphocyte‐mediated cytotoxicity againts tumour target cells. I. The effect of malignant diseaseInternational Journal of Cancer, 1976
- Properties of the K562 cell line, derived from a patient with chronic myeloid leukemiaInternational Journal of Cancer, 1976
- Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulationsInternational Journal of Cancer, 1975
- Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.Proceedings of the National Academy of Sciences, 1975
- Relations of HL‐A and Rh Systems to Immune ReactivityVox Sanguinis, 1974
- Lymphocyte-Mediated Cytotoxicity And Blocking Serum Activity To Tumor AntigensPublished by Elsevier ,1974